A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
NCT07559474
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Insufficiency
Liver Diseases
Interventions
DRUG:
INCB123667
Sponsor
Incyte Corporation